影研医疗科技（上海）有限公司

As an imaging CRO, we provide end-to-end central imaging services for Phase I to Phase III clinical trials, committed to superior service quality and operational excellence. Our focus is on oncology, which accounts for the largest share of clinical trials globally; we have built significant expertise in this field. We collaborate with sponsors of all sizes, from large multinational pharmaceutical companies to small and medium-sized biotech firms. Our presence is global. With our headquarters in Europe (France) and subsidiaries in the US and China (Shanghai), we deliver globally, offering best-in-class imaging services to biopharmaceutical clients. We also partner with leading CROs, enhancing their traditional clinical trial expertise with our imaging solutions. Currently, we are actively working with over 1,400 investigative sites worldwide and more than 45 biopharmaceutical sponsors.